= 0.04) with distant recurrence-free survival as end point. CXCR3, but not CXCL
= 0.04) with distant recurrence-free survival as finish point. CXCR3, but not CXCL10 is a prognostic element in breast cancer Within the following analysis, the capability of CXCL10 and CXCR3…